{"count": 43, "results": [{"_id": "37025791", "pmid": 37025791, "title": "Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic.", "journal": "Heliyon", "authors": ["Jamaluddin J", "Mohamed-Yassin MS", "Jamil SN", "Mohamed Kamel MA", "Yusof MY"], "date": "2023-03-29T00:00:00Z", "doi": "10.1016/j.heliyon.2023.e14998", "meta_date_publication": "2023 Apr", "meta_volume": "9", "meta_issue": "4", "meta_pages": "e14998", "score": 50239.51, "text_hl": "@SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ (@<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@) are at increased risk of cardiovascular events. ", "citations": {"NLM": "Jamaluddin J, Mohamed-Yassin MS, Jamil SN, Mohamed Kamel MA, Yusof MY. Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic. Heliyon. 2023 Apr;9(4):e14998. PMID: 37025791", "BibTeX": "@article{37025791, title={Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic.}, author={Jamaluddin J and Mohamed-Yassin MS and Jamil SN and Mohamed Kamel MA and Yusof MY}, journal={Heliyon}, volume={9}, number={4}, pages={e14998}}"}}, {"_id": "26543646", "pmid": 26543646, "pmcid": "PMC4620414", "title": "The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease", "journal": "Int J Nephrol", "authors": ["Satirapoj B", "Promrattanakun A", "Supasyndh O", "Choovichian P"], "date": "2015-01-01T00:00:00Z", "doi": "10.1155/2015/485839", "meta_date_publication": "2015", "meta_volume": "2015", "meta_issue": "", "meta_pages": "485839", "score": 50071.312, "text_hl": "The Effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ on @DISEASE_Proteinuria @DISEASE_MESH:D011507 @@@Proteinuria@@@ and Renal Function in @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@Chronic Kidney Disease@@@", "citations": {"NLM": "Satirapoj B, Promrattanakun A, Supasyndh O, Choovichian P. The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease Int J Nephrol. 2015;2015():485839. PMID: 26543646", "BibTeX": "@article{26543646, title={The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease}, author={Satirapoj B and Promrattanakun A and Supasyndh O and Choovichian P}, journal={Int J Nephrol}, volume={2015}, pages={485839}}"}}, {"_id": "28460629", "pmid": 28460629, "pmcid": "PMC5412040", "title": "Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection", "journal": "BMC Nephrol", "authors": ["Reith C", "Staplin N", "Herrington WG", "Stevens W", "Emberson J", "Haynes R", "Mafham M", "Armitage J", "Cass A", "Craig JC", "Jiang L", "Pedersen T", "Baigent C", "Landray MJ", "SHARP Collaborative Group"], "date": "2017-05-01T00:00:00Z", "doi": "10.1186/s12882-017-0545-2", "meta_date_publication": "2017 May 1", "meta_volume": "18", "meta_issue": "1", "meta_pages": "147", "score": 50070.695, "text_hl": "The Study of Heart @DISEASE_Glycosuria_Renal @DISEASE_MESH:D006030 @@@and Renal@@@ Protection (SHARP) randomized @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@ to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 20 mg plus @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ 10 mg (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@/@CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@) daily versus matching placebo. ", "citations": {"NLM": "Reith C, Staplin N, Herrington WG, Stevens W, Emberson J, Haynes R, Mafham M, Armitage J, Cass A, Craig JC, Jiang L, Pedersen T, Baigent C, Landray MJ, SHARP Collaborative Group. Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection BMC Nephrol. 2017 May 1;18(1):147. PMID: 28460629", "BibTeX": "@article{28460629, title={Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection}, author={Reith C and Staplin N and Herrington WG and Stevens W and Emberson J and Haynes R and Mafham M and Armitage J and Cass A and Craig JC and Jiang L and Pedersen T and Baigent C and Landray MJ and SHARP Collaborative Group}, journal={BMC Nephrol}, volume={18}, number={1}, pages={147}}"}}, {"_id": "23293535", "pmid": 23293535, "pmcid": "PMC3534534", "title": "Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review", "journal": "Int J Nephrol Renovasc Dis", "authors": ["Naderi S", "Foody JM"], "date": "2012-01-01T00:00:00Z", "doi": "10.2147/IJNRD.S28159", "meta_date_publication": "2012", "meta_volume": "5", "meta_issue": "", "meta_pages": "165-9", "score": 50070.34, "text_hl": "@CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@Ezetimibe@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@", "citations": {"NLM": "Naderi S, Foody JM. Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review Int J Nephrol Renovasc Dis. 2012;5():165-9. PMID: 23293535", "BibTeX": "@article{23293535, title={Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review}, author={Naderi S and Foody JM}, journal={Int J Nephrol Renovasc Dis}, volume={5}, pages={165-9}}"}}, {"_id": "26111494", "pmid": 26111494, "title": "Intensive perioperative simvastatin treatment protects from chronic kidney allograft injury.", "journal": "Am J Nephrol", "authors": ["Palin NK", "Savikko J", "Rintala JM", "Koskinen PK"], "date": "2015-01-01T00:00:00Z", "doi": "10.1159/000431338", "meta_date_publication": "2015", "meta_volume": "41", "meta_issue": "4-5", "meta_pages": "383-91", "score": 50069.97, "text_hl": "Intensive perioperative @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment protects from @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney allograft injury@@@.", "citations": {"NLM": "Palin NK, Savikko J, Rintala JM, Koskinen PK. Intensive perioperative simvastatin treatment protects from chronic kidney allograft injury. Am J Nephrol. 2015;41(4-5):383-91. PMID: 26111494", "BibTeX": "@article{26111494, title={Intensive perioperative simvastatin treatment protects from chronic kidney allograft injury.}, author={Palin NK and Savikko J and Rintala JM and Koskinen PK}, journal={Am J Nephrol}, volume={41}, number={4-5}, pages={383-91}}"}}, {"_id": "28755807", "pmid": 28755807, "title": "Cholesterol lowering treatment restores blood global DNA methylation in chronic kidney disease (CKD) patients.", "journal": "Nutr Metab Cardiovasc Dis", "authors": ["Zinellu A", "Sotgia S", "Sotgiu E", "Assaretti S", "Baralla A", "Mangoni AA", "Satta AE", "Carru C"], "date": "2017-09-01T00:00:00Z", "doi": "10.1016/j.numecd.2017.06.011", "meta_date_publication": "2017 Sep", "meta_volume": "27", "meta_issue": "9", "meta_pages": "822-829", "score": 50066.05, "text_hl": "METHODS AND RESULTS: DNA methylation and OS indices (@CHEMICAL_Malondialdehyde @CHEMICAL_MESH:D008315 @@@malonyldialdehyde@@@, @CHEMICAL_3_4_Methylenedioxyamphetamine @CHEMICAL_MESH:D015104 @@@MDA@@@; @CHEMICAL_Allantoin @CHEMICAL_MESH:D000481 @@@allantoin@@@/@CHEMICAL_Uric_Acid @CHEMICAL_MESH:D014527 @@@uric acid@@@ ratio, All/UA) were measured in 30 @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@ @SPECIES_9606 @@@patients@@@ randomized to three @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ lowering regimens for 12 months (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg/day, @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 10/20 mg/day, or @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 10/40 mg/day) and 30 age- and sex-matched healthy controls. ", "citations": {"NLM": "Zinellu A, Sotgia S, Sotgiu E, Assaretti S, Baralla A, Mangoni AA, Satta AE, Carru C. Cholesterol lowering treatment restores blood global DNA methylation in chronic kidney disease (CKD) patients. Nutr Metab Cardiovasc Dis. 2017 Sep;27(9):822-829. PMID: 28755807", "BibTeX": "@article{28755807, title={Cholesterol lowering treatment restores blood global DNA methylation in chronic kidney disease (CKD) patients.}, author={Zinellu A and Sotgia S and Sotgiu E and Assaretti S and Baralla A and Mangoni AA and Satta AE and Carru C}, journal={Nutr Metab Cardiovasc Dis}, volume={27}, number={9}, pages={822-829}}"}}, {"_id": "19034875", "pmid": 19034875, "title": "Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.", "journal": "J Nephrol", "authors": ["Dummer CD", "Thome' FS", "Zingano B", "Lindoso A", "Veronese FV"], "date": "2008-11-01T00:00:00Z", "meta_date_publication": "2008 Nov-Dec", "meta_volume": "21", "meta_issue": "6", "meta_pages": "900-8", "score": 50065.83, "text_hl": "Acute effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and oxidative stress in @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@.", "citations": {"NLM": "Dummer CD, Thome' FS, Zingano B, Lindoso A, Veronese FV. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease. J Nephrol. 2008 Nov-Dec;21(6):900-8. PMID: 19034875", "BibTeX": "@article{19034875, title={Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.}, author={Dummer CD and Thome' FS and Zingano B and Lindoso A and Veronese FV}, journal={J Nephrol}, volume={21}, number={6}, pages={900-8}}"}}, {"_id": "28753656", "pmid": 28753656, "pmcid": "PMC5533333", "title": "Simvastatin dose and acute kidney injury without concurrent serious muscle injury: A nationwide nested case-control study", "journal": "PLoS One", "authors": ["Parkin L", "Sharples KJ", "Barson DJ", "Blank ML"], "date": "2017-07-28T00:00:00Z", "doi": "10.1371/journal.pone.0182066", "meta_date_publication": "2017", "meta_volume": "12", "meta_issue": "7", "meta_pages": "e0182066", "score": 50065.23, "text_hl": "The rate in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ users with a history of non-dialysis dependent @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ was much higher at 88 (95% CI 73-105) per 10,000 person-years (based on 112 cases, including three of six for whom no controls were found, and 12,744 person-years of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ exposure).", "citations": {"NLM": "Parkin L, Sharples KJ, Barson DJ, Blank ML. Simvastatin dose and acute kidney injury without concurrent serious muscle injury: A nationwide nested case-control study PLoS One. 2017;12(7):e0182066. PMID: 28753656", "BibTeX": "@article{28753656, title={Simvastatin dose and acute kidney injury without concurrent serious muscle injury: A nationwide nested case-control study}, author={Parkin L and Sharples KJ and Barson DJ and Blank ML}, journal={PLoS One}, volume={12}, number={7}, pages={e0182066}}"}}, {"_id": "24996489", "pmid": 24996489, "title": "Comparison of the efficacy and safety profile of morning administration of controlled-release simvastatin versus evening administration of immediate-release simvastatin in chronic kidney disease patients with dyslipidemia.", "journal": "Clin Ther", "authors": ["Yi YJ", "Kim HJ", "Jo SK", "Kim SG", "Song YR", "Chung W", "Han KH", "Lee CH", "Hwang YH", "Oh KH"], "date": "2014-08-01T00:00:00Z", "doi": "10.1016/j.clinthera.2014.06.005", "meta_date_publication": "2014 Aug 1", "meta_volume": "36", "meta_issue": "8", "meta_pages": "1182-90", "score": 50061.84, "text_hl": "IMPLICATIONS: The efficacy of morning administration of CR @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was noninferior to evening administration of IR @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@CKD@@@. ", "citations": {"NLM": "Yi YJ, Kim HJ, Jo SK, Kim SG, Song YR, Chung W, Han KH, Lee CH, Hwang YH, Oh KH. Comparison of the efficacy and safety profile of morning administration of controlled-release simvastatin versus evening administration of immediate-release simvastatin in chronic kidney disease patients with dyslipidemia. Clin Ther. 2014 Aug 1;36(8):1182-90. PMID: 24996489", "BibTeX": "@article{24996489, title={Comparison of the efficacy and safety profile of morning administration of controlled-release simvastatin versus evening administration of immediate-release simvastatin in chronic kidney disease patients with dyslipidemia.}, author={Yi YJ and Kim HJ and Jo SK and Kim SG and Song YR and Chung W and Han KH and Lee CH and Hwang YH and Oh KH}, journal={Clin Ther}, volume={36}, number={8}, pages={1182-90}}"}}, {"_id": "18095904", "pmid": 18095904, "title": "Ezetimibe plus simvastatin cardiovascular outcomes study program.", "journal": "Expert Rev Cardiovasc Ther", "authors": ["Padial LR"], "date": "2008-01-01T00:00:00Z", "doi": "10.1586/14779072.6.1.17", "meta_date_publication": "2008 Jan", "meta_volume": "6", "meta_issue": "1", "meta_pages": "17-25", "score": 50059.047, "text_hl": "Four major outcome trials are underway to study the effect of @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ plus @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in different subsets of high-risk @SPECIES_9606 @@@patients@@@: familiar @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@, @DISEASE_Aortic_Valve_Stenosis @DISEASE_MESH:D001024 @@@degenerative aortic stenosis@@@, @<m>DISEASE_Renal_Insufficiency_Chronic</m> @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ and @DISEASE_Acute_Coronary_Syndrome @DISEASE_MESH:D054058 @@@acute coronary syndrome@@@. ", "citations": {"NLM": "Padial LR. Ezetimibe plus simvastatin cardiovascular outcomes study program. Expert Rev Cardiovasc Ther. 2008 Jan;6(1):17-25. PMID: 18095904", "BibTeX": "@article{18095904, title={Ezetimibe plus simvastatin cardiovascular outcomes study program.}, author={Padial LR}, journal={Expert Rev Cardiovasc Ther}, volume={6}, number={1}, pages={17-25}}"}}]}